Dr. Stanley Rose joined NimbleGen as President and Chief Executive Officer in 2003 and serves as a member of the company's Board of Directors. Dr. Rose directed the PCR business during its most dynamic growth phases for Perkin-Elmer and Applied Biosystems and founded Genetic MicroSystems, a microarray products company that was sold to Affymetrix in 2000. He received his B.A. from Cornell University and his Ph.D. from the Massachusetts Institute of Technology.